Fludarabine Phosphate (Fludara)

DRUG4 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

Leukemia, Lymphocytic, Chronic, B-CellLymphomaLymphoma, Low-GradeNon Hodgkin Lymphoma

Phase 2

Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

CompletedNCT00185445

Genzyme, a Sanofi CompanyNon Hodgkin Lymphoma

Start: 2004-06-30End: 2006-10-31Updated: 2013-12-04

Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL

CompletedNCT00311129

Genzyme, a Sanofi CompanyLymphoma, Low-Grade

Start: 2005-12-31End: 2007-07-31Updated: 2013-12-04

Fludara (Oral) Phase II Study for Indolent Lymphoma

CompletedNCT00688883

Genzyme, a Sanofi CompanyLymphoma

Start: 2003-02-28End: 2004-08-31Updated: 2013-12-04

Phase 4

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

CompletedNCT00220311

Genzyme, a Sanofi CompanyLeukemia, Lymphocytic, Chronic, B-Cell

Start: 2000-11-30End: 2005-09-30Updated: 2013-12-04